Zinnwald Lithium plc / EPIC: ZNWD.L / Market: AIM / Sector: Mining
25 April 2023
Zinnwald Lithium plc
("Zinnwald Lithium" or the "Company")
Appointment of Non-Executive Director
Zinnwald Lithium plc, the German focused lithium development company, is pleased to announce the appointment of Dr. Stefan Scherer as a Non-Executive Director in accordance with the terms of the Relationship Agreement with AMG Advanced Metallurgical Group N.V. ("AMG") announced on 22 March 2023.
As Chief Executive Officer of AMG Lithium GmbH and Chief Commercial Officer of AMG Lithium BV, Dr. Scherer is responsible for AMG's downstream Lithium business as well as the overall strategy development for its entire Lithium operations. After his studies in chemistry at the Technische Hochschule Darnstadt, Dr. Scherer completed his PhD in Organic Chemistry at the Goethe University in Frankfurt in 1995. He has more than 20 years' experience in the speciality and fine chemical industries in various R&D, operational and management positions, including periods with Albermarle and Rockwood Lithium/Chemetall, prior to joining AMG in 2019. Dr. Scherer is a German citizen.
Zinnwald Lithium CEO, Anton du Plessis, said: "We are delighted to welcome Dr. Stefan Scherer to the Board. He brings significant lithium industry experience that will be extremely relevant to our advanced integrated lithium hydroxide project located in Saxony and a wealth of contacts within the German business community, which will be invaluable as we move forward."
Disclosures under Schedule 2 of the AIM Rules
Dr. Scherer, aged 55, holds or has held the following directorships and/or partnerships in the previous five years.
| Present Directorships / Partnerships | Past Directorships / Partnerships |
| AMG Lithium GmbH (Germany) AMG Lithium B.V. (Netherlands) | Albermarle Germany GmbH |
Dr. Scherer does not directly hold any shares nor options over ordinary shares in the Company. He is the appointed representative of AMG, which owns 25.1% of the Company.
There is no further information which is required to be disclosed under Schedule Two, paragraph (g) of the AIM Rules for Companies in respect of Dr. Scherer.
*ENDS*
For further information visit www.zinnwaldlithium.com or contact:
| Anton du Plessis Cherif Rifaat | Zinnwald Lithium plc | info@zinnwaldlithium.com |
| David Hart Dan Dearden-Williams | Allenby Capital (Nominated Adviser) | +44 (0) 20 3328 5656 |
| Michael Seabrook Adam Pollock | Oberon Capital Ltd (Joint Broker) | +44 (0) 20 3179 5300 |
| Richard Greenfield Charles Bendon | Tamesis Partner LLP (Joint Broker) | +44 (0) 20 3882 2868 |
| Isabel de Salis Paul Dulieu | St Brides Partners (Financial PR) | zinnwald@stbridespartners.co.uk
|
Notes
AIM quoted Zinnwald Lithium plc (EPIC: ZNWD.L) is focussed on becoming an important supplier of lithium hydroxide to Europe's fast-growing battery sector. The Company owns 100% of the Zinnwald Lithium Project in Germany, which has an approved mining licence, is located in the heart of Europe's chemical and automotive industries and has the potential to be one of Europe's more advanced battery grade lithium projects.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.